The court heard testimony from an industrial psychologist who said that incident has negatively affected the boy ...

Right now, the TN Dept. of Education (TDOE) requires school districts to count end-of-course exams in high school toward ...

An Athens man has been arrested on multiple charges after police say he attempted to pose as an officer from the Athens ...

Long-term follow-up showed continued meaningful responses in patients with relapsed or refractory KMT2Ar acute leukemia who were treated with revumenib, with no new safety signals found.

WASHINGTON, D.C. - A 5th grade student brought a replica gun to school in D.C., according to school officials. In a letter ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets ...

Rigel Pharmaceuticals (RIGL) announced initial data from its ongoing Phase 1b study evaluating R2891, an oral prodrug of R835, a potent and ...

Taking a deeper look at who played and what kind of performance they put on the board out of the 34-31 win over SMU.

Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 – – 100% of 1L NPM1-m and 96% of 1L KMT2A-r AML patients alive ...

This article has no body content. Login to continue reading Login Sign up for complimentary access Sign Up Now Close ...

Updated results from the phase 2 AUGMENT-101 trial showed that revumenib continued to provide clinically meaningful responses ...